The US Food and Drug Administration (FDA) has granted 510(k) clearance for Johnson & Johnson (J&J) MedTech’s Monarch Quest intended for robotic-assisted bronchoscopy procedures.
This solution is stated to be the newest advancement in the company’s Monarch navigation technology featuring AI-powered algorithms and a verified OEC Open interface with GE HealthCare’s OEC 3D mobile cone-beam computed tomography (CBCT) imaging system.
Go deeper with GlobalData
According to J&J, the Monarch Quest platform is said to be the first robotic-assisted bronchoscopy system on the US market offering visualisation and minimally invasive access to airways. This is critical for the biopsy of suspicious lung nodules.
The system aids clinicians in achieving an early diagnosis in cases of lung cancer and helps expedite the treatment process by an average of three weeks.
With its scope-in-sheath design, Monarch Quest provides physicians with a continuous vision.
The company stated that the software’s integration with intraprocedural three-dimensional imaging data has the potential to significantly boost accuracy in aiming at lung nodules.
Its AI navigation utilises the Nvidia accelerated computing platform, which boosts the real-time computational power of the device by 260%.
Monarch Quest is also designed to accommodate additional AI competencies in coming software releases.
The platforms’ digital capabilities span from preoperative planning to intraoperative AI-based navigation for enhancing post-operative case data analysis.
J&J MedTech Monarch president Aleksandra Popovic said: “Our goal with the Monarch Platform is to change the treatment paradigm for diseases such as lung cancer, where significant unmet needs still remain.
“Monarch Quest demonstrates our commitment to delivering meaningful innovation that helps clinicians advance the standard of care for their patients.”
In the US, the Monarch Bronchoscope, along with the Monarch Platform and its accessories, is indicated for bronchoscopic visualisation of and access to an individual’s airways, for both therapeutic and diagnostic procedures.
